EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer

Aditya Bardia, Philippe Aftimos, Teeru Bihani, Alfred T. Anderson-Villaluz, Jungah Jung, Maureen G. Conlan, Virginia G. Kaklamani

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences